Algorithm-Optimized H5 Influenza mRNA Vaccine Induces Broad Immune Responses
International Journal of Molecular Sciences · 19.05.2026 · 27 (10) · 4547
DOI: 10.3390/ijms27104547 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.05.2026. Verfasst von Liangliang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIF…. Hauptthemen laut MEDLINE: Influenza Vaccines, Hemagglutinin Glycoproteins, Influenza Virus, Influenza A Virus, H5N1 Subtype, Influenza, Human. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory of Drug Regulatory Science, Beijing Natural Science Foundation.
Abstract (Originalsprache)
The high case fatality rate, cross-species transmission, and ongoing evolution of H5 avian influenza viruses pose an imminent threat of an influenza pandemic, particularly with the currently predominant clade 2.3.4.4b lineage. Existing seasonal influenza vaccines and licensed H5 vaccines provide limited cross-protection against H5 viruses, underscoring an urgent need for the development of broadly protective H5 vaccines. In this study, we analyzed all human-infected H5 hemagglutinin (HA) sequences using bioinformatics approaches and subsequently designed a novel H5 influenza vaccine through algorithm optimization. The predicted structure of this vaccine closely resembles that of the wild-type H5 HA trimer. In animal studies, the algorithm-optimized H5 mRNA vaccine not only induced high levels of neutralizing antibodies against multiple clade 2.3.4.4b H5 viruses but also elicited cross-neutralizing antibodies against clade 2.3.4.4 and clade 2.2.1 H5 viruses, as well as robust cellular immune responses. These findings highlight the potential of algorithm-based approaches in developing broadly protective vaccines against pandemic viruses and suggest that this vaccine candidate could serve as a strategic stockpile for preventing H5 influenza pandemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China.
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
- State Key Laboratory of Drug Regulatory Science, Beijing 102629, China.
- Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.
ORCID-Profile: Chenchen He, Weijin Huang, Chenyan Zhao
Förderung
- State Key Laboratory of Drug Regulatory Science
- Beijing Natural Science Foundation
Zitieren
APA
Wang, L., Peng, Z., He, C., Zhang, J., Yu, P., Huang, W., Wang, Y., & Zhao, C. (2026). Algorithm-Optimized H5 Influenza mRNA Vaccine Induces Broad Immune Responses. International Journal of Molecular Sciences, 27(10), 4547. https://doi.org/10.3390/ijms27104547
Vancouver
Wang L, Peng Z, He C, Zhang J, Yu P, Huang W, et al. Algorithm-Optimized H5 Influenza mRNA Vaccine Induces Broad Immune Responses. International Journal of Molecular Sciences. 2026;27(10):4547. doi:10.3390/ijms27104547
BibTeX
@article{Wang2026,
author = {Wang, Liangliang and Peng, Zhengda and He, Chenchen and Zhang, Jie and Yu, Pengju and Huang, Weijin and Wang, Youchun and Zhao, Chenyan},
title = {Algorithm-Optimized H5 Influenza mRNA Vaccine Induces Broad Immune Responses},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4547},
doi = {10.3390/ijms27104547}
}
EUVIMED